Skip to main content
. 2014 Jun 25;307(4):F427–F434. doi: 10.1152/ajprenal.00072.2014

Fig. 4.

Fig. 4.

A: adding 10−5 mol/l eplerenone to the CNT perfusate prevented the sensitization of CTGF by aldosterone, suggesting that this effect is mediated by either the mineralocorticoid receptor (MR) or G protein-coupled receptor 30 (GPR30). B: eplerenone alone did not affect CTGF in the absence of exogenous aldosterone.